Reports Q2 revenue $10.85B, consensus $10.68B. “Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment. The agility of our organization, powered by the PPI Business System, allowed us to effectively adapt to current market conditions, actively manage our cost base, and deliver strong operational results in the second quarter,” said Marc N. Casper, chairman, president, and chief executive officer of Thermo Fisher (TMO) Scientific. Casper added: “Our trusted partner status is resonating strongly with our customers allowing us to continue to drive market share gains and highlights our unique ability to enable their success in all market environments. We’ve made very good progress through the halfway point in the year, which positions us well to deliver on our 2025 commitments, while building an even brighter future for our company.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Notable companies reporting before tomorrow’s open
- TMO Earnings this Week: How Will it Perform?
- Thermo Fisher price target lowered to $553 from $573 at Baird
- ‘Too Cheap to Ignore’: Scotiabank Says There’s an Opportunity Brewing in These 2 Large Cap Healthcare Stocks
- Thermo Fisher to acquire Sanofi steriles manufacturing site in New Jersey